Jan Konvalinka
Jan Konvalinka is a prominent Czech biochemist and director of the Institute of Organic Chemistry and Biochemistry at the Czech Academy of Sciences. He has made significant contributions to the field of virology, particularly in the development of antiviral therapies. Recently, he gained attention for his role in explaining the innovative mechanism of the HIV prevention drug Lenacapavir, which blocks the viral capsid protein, preventing the proper assembly of viral particles.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Slovakia:
Jan Konvalinka is the director of the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, who explained the mechanism of the drug.
8